15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 11 firms covering Imax Corp, 9 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $41.00 to $60.00, a moderate spread. The average target of $49.55 sits 5% above the current $47.30. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.74 next quarter toward $2.09 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 ratings
Strong Buy
Strong Buy00%
Buy982%
Hold218%
Sell00%
Strong Sell00%
Based on 11 analysts giving stock ratings to Imax Corp.
As of Jul, 9 of 11 firms rate IMAX a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
IMAX EPS & revenue forecast
EPS · NEXT QUARTER
$0.74
Range $0.62 – $1.03 · 7 analysts · +27% YoY
Next period, 7 analysts expect Imax Corp to earn $0.74 a share (range $0.62 – $1.03), versus $0.58 a year earlier. Full-year consensus is $1.84, growing to $2.09 the year after.
REVENUE · NEXT QUARTER
$141.3M
Range $131.9M – $156.0M · 7 analysts · +13% YoY
Revenue is expected to reach $141.3M (range $131.9M – $156.0M), +12.9% year-over-year. Full-year consensus is $444.2M, rising to $471.7M next year.
Top analysts covering Imax Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IMAX.
#1
David Karnovsky
JP Morgan · Rank #201
Buy
$50.00+5.7% to target
Overall win rate
36%
+ Follow
#2
Michael Pachter
Wedbush · Rank #304
Buy
$54.00+14.2% to target
Overall win rate
34%
+ Follow
#3
Mike Hickey
Benchmark · Rank #339
Buy
$60.00+26.8% to target
Overall win rate
33%
+ Follow
#4
SF
Steve Frankel
Rosenblatt
Buy
$50.00+5.7% to target
Coverage
—
+ Follow
#5
PS
Patrick Sholl
Barrington Research
Buy
$50.00+5.7% to target
Coverage
—
+ Follow
IMAX stock forecast FAQ
What is IMAX's average 12-month price target?+
The 11 analysts with a live target average $49.55 for Imax Corp over the next 12 months, ranging from a $60.00 high to a $41.00 low.
Is IMAX stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 11 analyst ratings, 9 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for IMAX?+
The Street-high target is $60.00 (Benchmark), and the Street-low is $41.00 (Goldman Sachs). The average of all 11 active targets is $49.55.
How many Wall Street analysts cover IMAX?+
11 analysts have an active rating on Imax Corp, and 11 firms carry a live 12-month price target.
Who is the most accurate analyst covering IMAX?+
Among analysts who currently cover IMAX, David Karnovsky of JP Morgan has the strongest overall Quantellect track record (Rank #201). Their current call is Buy with a $50.00 target.
What is Imax Corp's projected EPS for next quarter?+
The consensus estimate is $0.74 per share (range $0.62 – $1.03) across 7 analysts. Full-year EPS is projected at $1.84, rising to $2.09 the following year.
How much revenue is Imax Corp expected to report next quarter?+
Consensus revenue is $141.3M (range $131.9M – $156.0M). Full-year revenue is projected at $444.2M, growing to $471.7M next year.
Have analysts been upgrading or downgrading IMAX lately?+
As of Jul, 9 of 11 firms rate IMAX a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IMAX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
